Fennec Pharmaceuticals, Inc. (FENC)
8.005
+0.20
(+2.63%)
USD |
NASDAQ |
Mar 17, 12:44
Fennec Pharmaceuticals EPS Diluted (Quarterly) : -0.0229 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | -0.2898 |
| REGENXBIO, Inc. | -1.298 |
| Zymeworks, Inc. | -0.547 |
| Apellis Pharmaceuticals, Inc. | -0.4654 |
| Gossamer Bio, Inc. | -0.2115 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.638M |
| Revenue (Quarterly) | 12.46M |
| Total Expenses (Quarterly) | 13.10M |
| Enterprise Value | 262.56M |
| Gross Profit Margin (Quarterly) | 94.70% |
| Profit Margin (Quarterly) | -5.12% |
| Earnings Yield | -2.97% |
| Normalized Earnings Yield | -2.952 |